
    
      Patients will receive three weeks of whole brain radiation therapy concurrent with daily
      motexafin gadolinium during weeks 2 and 3, followed by a stereotactic radiosurgery boost
      concurrent with motexafin gadolinium. Patients will be followed for radiologic response,
      neurologic progression, and neurocognitive progression.
    
  